Search

Author/Creator Machackova, Z.

1. Efficacy and safety of subcutaneous trastuzumab and intravenous trastuzumab as part of adjuvant therapy for HER2-positive early breast cancer: Final analysis of the randomised, two-cohort PrefHer study. (November 2017)

Authors:
Pivot, X.; Verma, S.; Fallowfield, L.; Müller, V.; Lichinitser, M.; Jenkins, V.; Sánchez Muñoz, A.; Machackova, Z.; Osborne, S.; Gligorov, J.
Journal:
European journal of cancer
Issue:
Volume 86(2017)
Page Start:
82
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search